bpc-157 fda warning news today compounding safety risks NBC fda bpc 157 warning 2025

Storage and Handling (Research Use) Store unopened vials at 28C , protected from light and moisture

Any haze or cloudiness that develops over time is a strong indicator of bacterial contamination or peptide aggregation

Swab the top of the vial with a 95% alcohol wipe before accessing

PubMed record Khavinson VK, et al

Patients who report the most dramatic energy improvements from SS-31 are typically those with pre-existing mitochondrial dysfunction whether from aging, chronic illness, or metabolic stress

GLP-1 agonists are highly regulated, FDA-approved prescription medications with defined dosing protocols and monitored side-effect profiles